These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7679923)

  • 21. Single strand targeted triplex formation: targeting purine-pyrimidine mixed sequences using abasic linkers.
    Kandimalla ER; Manning AN; Venkataraman G; Sasisekharan V; Agrawal S
    Nucleic Acids Res; 1995 Nov; 23(21):4510-7. PubMed ID: 7501477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bend in RNA created by the trans-activation response element bulge of human immunodeficiency virus is straightened by arginine and by Tat-derived peptide.
    Zacharias M; Hagerman PJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6052-6. PubMed ID: 7597079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA binding assays for Tat-derived peptides: implications for specificity.
    Weeks KM; Crothers DM
    Biochemistry; 1992 Oct; 31(42):10281-7. PubMed ID: 1384694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rotational symmetry in ribonucleotide strand requirements for binding of HIV-1 Tat protein to TAR RNA.
    Barnett RW; Delling U; Kuperman R; Sonenberg N; Sumner-Smith M
    Nucleic Acids Res; 1993 Jan; 21(1):151-4. PubMed ID: 8441609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.
    Cordingley MG; LaFemina RL; Callahan PL; Condra JH; Sardana VV; Graham DJ; Nguyen TM; LeGrow K; Gotlib L; Schlabach AJ
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8985-9. PubMed ID: 2247474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
    Jayasena SD; Johnston BH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of HIV-1 Tat(32-72) with its target RNA: a fluorescence and nuclear magnetic resonance study.
    Metzger AU; Bayer P; Willbold D; Hoffmann S; Frank RW; Goody RS; Rösch P
    Biochem Biophys Res Commun; 1997 Dec; 241(1):31-6. PubMed ID: 9405229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
    Naryshkin NA; Gait MJ; Ivanovskaya MG
    Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro selection of RNA aptamers that can bind specifically to Tat protein of HIV-1.
    Yamamoto R; Toyoda S; Viljanen P; Machida K; Nishikawa S; Murakami K; Taira K; Kumar PK
    Nucleic Acids Symp Ser; 1995; (34):145-6. PubMed ID: 8841594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major groove opening at the HIV-1 Tat binding site of TAR RNA evidenced by a rhodium probe.
    Neenhold HR; Rana TM
    Biochemistry; 1995 May; 34(19):6303-9. PubMed ID: 7756257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How Tat targets TAR: structure of the BIV peptide-RNA complex.
    Greenbaum NL
    Structure; 1996 Jan; 4(1):5-9. PubMed ID: 8805518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
    Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
    Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
    Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of site-specifically modified oligoribonucleotides for studies of the recognition of TAR RNA by HIV-1 tat protein and studies of hammerhead ribozymes.
    Slim G; Pritchard C; Biala E; Asseline U; Gait MJ
    Nucleic Acids Symp Ser; 1991; (24):55-8. PubMed ID: 1841380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction.
    Jeyapaul J; Seshamma T; Khan SA
    Oncogene; 1991 Sep; 6(9):1507-13. PubMed ID: 1923518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S; Cao H; Rana TM
    Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
    Rana TM; Jeang KT
    Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.